Table 3. Clinical and echocardiographic variables as determinants of VO2 peak.
Univariate |
Multivariate |
|||||
β | t | P | β | t | P | |
Age | −0.390 | −5.062 | < 0.001 | −0.274 | −3.559 | 0.001 |
Gender (female) | −0.351 | −4.489 | < 0.001 | −0.239 | −3.500 | 0.001 |
BMI | −0.017 | −0.220 | 0.826 | |||
Hypertension | −0.063 | −0.824 | 0.411 | |||
Diabetes mellitus | −0.049 | −0.634 | 0.527 | |||
Current smokers | −0.036 | −0.470 | 0.639 | |||
β-blockers | −0.109 | −1.434 | 0.153 | |||
Heart rate rest | −0.019 | −0.226 | 0.822 | |||
Heart rate peak | −0.046 | −0.537 | 0.592 | |||
LVMI | −0.048 | −0.504 | 0.615 | |||
LVEF | −0.099 | −1.147 | 0.253 | |||
LAA | −0.013 | −0.148 | 0.883 | |||
E velocity rest | 0.071 | 0.928 | 0.355 | |||
e' rest | 0.360 | 5.038 | < 0.001 | |||
E/e' rest | −0.402 | −5.725 | < 0.001 | |||
E velocity stress | 0.025 | 0.321 | 0.748 | |||
e' stress | 0.467 | 6.877 | < 0.001 | |||
E/e' stress | −0.632 | −9.746 | < 0.001 | −0.530 | −7.614 | < 0.001 |
LnNT-proBNP | −0.165 | −1.999 | 0.048 |
BMI: body mass index; E: early diastolic mitral inflow velocity; e': early diastolic mitral annular velocity; LAA: left atrial area; LVEF: Left ventricular ejection fraction; LVMI: left ventricular mass index; NT-proBNP: N-terminal pro-B-type natriuretic peptide; VO2 peak: peak oxygen uptake.